Live Breaking News & Updates on Intercept Announces Positive Data

Stay updated with breaking news from Intercept announces positive data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Intercept Pharmaceuticals : Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA) - Form 8-K

Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid

OCA 25 mg met the agreed primary endpoint of. | July 7, 2022 ....

Nareg Sagherian , Karen Preble , Exchange Commission , Global Corporate Communications , Intercept Pharmaceuticals Inc , Securities Exchange , Intercept Announces Positive Data , New Analysis , Obeticholic Acid , Analysis Methodology , Randomized Global Phase , Obeticholic Acid Treatment , Liver Fibrosis , New Drug Application , Securities Act , Securities Exchange Act , Annual Report , Quarterly Report , Executive Director , Global Investor Relations , Intercept Pharmaceuticals , Nc Stock Exchange , Press Release , Ndpoint Icpt Us45845p1084 ,